Zahed Subhan

Zahed Subhan is an accomplished executive in the biopharmaceutical industry, currently serving as the Executive Chairman, Co-founder, and Director at Eppin Pharma Inc. He has over 30 years of experience in various senior roles across multinational pharmaceutical and biotechnology companies, including positions in research and development, marketing, sales, and strategic planning.

Subhan has co-founded multiple biotech firms, raising over $50 million in venture capital funding and achieving significant milestones such as initial public offerings (IPOs) and collaborations with major pharmaceutical companies. His previous roles include CEO of Aestas Pharma Inc. and Adhera Therapeutics, where he was involved in the development and commercialization of various pharmaceutical products. Notably, he has been instrumental in the successful launches of several widely recognized drugs and has established numerous partnerships valued at over $600 million in the industry.123

In addition to his executive roles, Subhan is also a Teaching Professor at Drexel University, where he focuses on entrepreneurship and innovation management, further contributing to the academic landscape in the field of biopharmaceuticals.2